Bristol-Myers Squibb CompanyBMYNYSE
Loading
Revenue PerformanceStrong
Percentile Rank93
3Y CAGR+1.4%
5Y CAGR+2.5%
Year-over-Year Change
Total revenue from sales of goods and services
3Y CAGR
+1.4%/yr
vs +19.6%/yr prior
5Y CAGR
+2.5%/yr
Consistent
Acceleration
-18.1pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $48.19B | -0.2% |
| 2024 | $48.30B | +7.3% |
| 2023 | $45.01B | -2.5% |
| 2022 | $46.16B | -0.5% |
| 2021 | $46.38B | +9.1% |
| 2020 | $42.52B | +62.6% |
| 2019 | $26.14B | +15.9% |
| 2018 | $22.56B | +8.6% |
| 2017 | $20.78B | +6.9% |
| 2016 | $19.43B | - |